Clinical Trials Directory

Trials / Completed

CompletedNCT01058122

Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward

Status
Completed
Phase
Study type
Observational
Enrollment
129 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed cohort study collected within a 5-month observation period adverse drug reaction (Adverse Drug Events - ADE) in patients at the Department of Oncology at the University of Zurich. ADE have been recorded using prospective monitoring and assessed using standardized algorithms regarding causality and severity. Data sources included information from the medical records, laboratory values and internal rounds. Additional information has been collected using a standardized patient questionnaire. The primary endpoints of this study are to determine the frequency of ADE, the comparison of the quality of data sources and collection methods for the detection of ADE in regard to patient characteristics, size, number of medications, the category of ADE, severity, causation, diagnosis, hospitalization, cause of hospitalization and medication cause. Secondary endpoint is the assessment of the ADE causality, severity and predictability.

Conditions

Interventions

TypeNameDescription
PROCEDURECollection of adverse drug events

Timeline

Start date
2007-08-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2010-01-28
Last updated
2018-05-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01058122. Inclusion in this directory is not an endorsement.

Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward (NCT01058122) · Clinical Trials Directory